Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES (left), and Michelle F. Magee, MD, MB, BCh, LRCPSI, will review the updated national standards for diabetes self-management education and support. A companion session will outline the revised certification program for certified diabetes care and education specialists.

The ADA and the European Association for the Study of Diabetes published a consensus report on precision diabetes medicine in 2020. Scientific Sessions attendees will get an update on this joint initiative during a special symposium on Saturday, June 4. John M. Dennis, PhD (left), and David Kerr, MD, are two of the featured presenters.

James D. Johnson, PhD (left), and Steven E. Kahn, MB, ChB, debated whether hyperinsulinemia is the primary defect that results in type 2 diabetes during a mini-symposium on Friday, June 3. “The big question is whether insulin resistance is primary or if hyperinsulinemia stimulates insulin resistance,” Dr. Johnson said.

The symposium will review the first findings from a key trial on the use of low-dose interleukin-2 in recently diagnosed type 1 diabetes. Experts will also look at past efforts at prevention and provide independent commentary on the trial results.

Amy K. Mottl, MD, MPH, FASN, will open the joint session, which brings together experts from various disciplines in an effort to improve screening, uptake of practice guidelines, and patient outcomes.

The mental health burden of diabetes remains “grossly underappreciated,” according to Katharine Barnard, PhD. She and other experts will discuss strategies to identify and provide support to diabetes patients at risk for suicide and self-harm.

Hollie Raynor, PhD, RD, and three other expert presenters will review the latest lessons learned for maximizing weight loss maintenance in the U.S. National Diabetes Prevention Program.

Person-centered care involves working with diabetes patients to determine the best treatment approaches to fit their lives. The best evidence and clinical guidelines don’t work for all individuals, according to Katherine S. O’Neal, PharmD, MBA, BCACP, CDCES, BC-ADM, CLS, FADCES.

A multidisciplinary panel including diabetes care and education specialists Jasmine D. Gonzalvo, PharmD, CDCES, BC-ADM (left), and Vivian N. Ayuk, PharmD, CDCES, will discuss educational strategies to help underserved populations overcome barriers to technology access.

Factors such as sex, gender, age, ethnicity, education, and living environment affect a person’s physical activity. Jane E. Yardley, PhD, and three other experts will share strategies for prescribing physical activity that are feasible and sustainable for various patient groups.